-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
-
Summary
-
Landos Biopharma, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2020 to 2023.
- Landos Biopharma, Inc. Share-based Payment Arrangement, Expense for the quarter ending March 31, 2024 was $260K, a 16.1% increase year-over-year.
- Landos Biopharma, Inc. Share-based Payment Arrangement, Expense for the twelve months ending March 31, 2024 was $1.01M, a 19.7% decline year-over-year.
- Landos Biopharma, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $971K, a 50.7% decline from 2022.
- Landos Biopharma, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $1.97M, a 52.1% decline from 2021.
- Landos Biopharma, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $4.12M, a 394% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)